DEPARTMENT OF CELL BIOLOGY Head: Dr. Jacek Bigda, Associate Professor Research Staff: Dr. Małgorzata Doszczak Dr. Patrycja Koszałka Dr. Zuzanna Dobrzańska.

Slides:



Advertisements
Similar presentations
Cancer Immunoediting Integrating Immunity’s Roles in Cancer Suppression and Promotion Omer GULLULU.
Advertisements

Signal Transduction Mechanisms Underlying Underlying Growth Control and Oncogenesis Ronit Sagi-Eisenberg Dept. of Cell and Developmental Biology Sackler.
Topics The Ag-specific T cell receptor
T cells Jan Novák. The immune system Protection against infectious agents Clearance of dying, damaged and dangerous cells Regulation of the immune responses.
Cytokines Non-antibody proteins acting as mediators between cells, termed: Monokines – mononuclear phagocytes Lymphokines – activated T cells, especially.
Therapeutic Implications and Prognostic Significance of c-Met in Esophageal Squamous Cell Cancer Ching Tzao 1, Chun-Ya Wang 1, Ban-Hen Chen 1, Guang-Huan.
Tumor Immunology: Definitions: -Tumor (neoplasm): unchecked cellular growth. -Two types: 1-Benign: controlled tumor. 2-Malignant: uncontrolled tumor. -Malignant.
Chapter 12 Cytokines Dr. Capers
Apoptosis-related Diseases  Insufficient apoptosis  Excessive apoptosis  Coexistence of insufficient and excessive apoptosis.
Advanced Cancer Topics Journal Review 4/16/2009 AD.
DEPARTMENT OF IMMUNOLOGY Chair of Histology and Immunology Medical University of Gda ń sk DEPARTMENT OF IMMUNOLOGY Chair of Histology and Immunology Medical.
Isosteviol derivatives induced apoptosis in Human lung cancer via targeting MEK/MAPK pathway: An in vitro and in vivo study Ahmed M Malki 1,,PhD Stephen.
Tumor Immunology Dr.Marián Sabol, PhD. P.J. Šafárik University, Medical Faculty, Institute of Medical Microbiology Tr. SNP 1, Košice, Slovakia.
Dental Microbiology #211 IMMUNOLOGY Lecture 5 Cellular Immunity: The functions of T cells.
Basic Immunology University of Tabuk Faculty of Applied Medical Science Department of Medical Laboratory Technology Mr.AYMAN.S.YOUSIF MSc.Medical Microbiology.
Jianzhong Chen, Ph.D. Institute of Immunology, ZJU.
The Response of Tumor Cells to Stress and Chemotherapy The Role of PKC Etta Livneh Faculty of Health Sciences.
IMIQUIMOD, AN IMMUNE-RESPONSE MODIFIER, IN THE TREATMENT OF TRANSITIONAL CELL CARCINOMA OF THE BLADDER Douglas Scherr, M.D. Department of Urology New York.
Effects of blue shark cartilage alkaline extract on cytokine secretions in bronchoalveolar lavage fluid of ovalbumin-sensitized and -challenged mice Mei-Chun.
Ribosomal Dysfunction Results in an Immunologic Susceptibility to Lung Cancer Stephanie Chang MD, Ryuji Higashikubo PhD, Saeed Arefanian MD, Andrew Gelman.
Specific Immune Responses How the Immune System Handles Specific Antigens.
Host Defense Against Tumors (Tumor Immunity)
Furan-Induced Cytotoxicity, Cell Proliferation, and Tumorgenicity in Mouse Liver Dr. Glenda Moser.
NAJRAN UNIVERSITY College of Medicine NAJRAN UNIVERSITY College of Medicine Microbiology &Immunology Course Lecture No. 17 Microbiology &Immunology Course.
Therapies targeting the Immune System:  Stimulation  Suppression  Modulation.
5. Cytokine 细胞因子 王家鑫,孟明 Department of Veterinary Immunology College of Animal Science and Technology Agricultural University of Hebei.
RISE Honors Seminar 2014 Ronald Doll RISE Dept. S-332 X 3168 Training – Synthetic Organic Chemist (Ph.D. Duke Univ.) - National Institute.
 Cytokine and Adipokine  TNFR1 and TNFR2  212 amino acids.
Cancer and the Immune System
Objectives Introduction Ags expressed by cancer cells
HOST DEFENCE AGAINST TUMORS:
Acute Radiation Syndromes. Implications for Immunotherapy
BDNF: brain-derived neurotrophic factor CRP: C-reactive protein
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
Copyright © 2003 American Medical Association. All rights reserved.
Cellular Immune response
CELL-MEDIATED IMMUNITY RAHUL KUMAR LOHANA 2K16/MB/50 INSTITUTE OF MICROBIOLOGY UNIVERSITY OF SINDH, JAMSHORO.
Tumor Immunity: Exploring the Role of a Checkpoint
Immunotherapy of hepatocellular carcinoma
Inducing Angiogenesis
CELL-MEDIATED IMMUNITY
Challenges in the Development of Effective Peptide Vaccines for Cancer
Discussion Outline Cells of the Immune System.
Immunologic pathomechanism of Hodgkin's lymphoma
Immunologic pathomechanism of Hodgkin's lymphoma
Volume 114, Issue 2, Pages (February 1998)
Markers of cancer cell and lymphocytes in inflammatory infiltration around a tumour as potential markers of immunomodulatory treatment response. Markers.
Megan E. Daly, MD, Arta M. Monjazeb, MD, PhD, Karen Kelly, MD 
Enhancement of depsipeptide-mediated apoptosis of lung or esophageal cancer cells by flavopiridol: Activation of the mitochondria-dependent death-signaling.
Identifying and Treating COPD in Cardiac Patients
Craig H Selzman, MD, Stephanie A Miller, MD, Alden H Harken, MD 
Moving Immune Checkpoint Blockade in Thoracic Tumors beyond NSCLC
Tumor Necrosis Factor Cell
Volume 143, Issue 1, Pages e3 (July 2012)
10.3 Regulating the Cell Cycle
Volume 3, Issue 5, Pages (May 2003)
Humoral and Cell Mediated Immunity
Experimental Hematology
The Dual Role of Bone Morphogenetic Proteins in Cancer
Therapeutic strategies in inflammasome mediated diseases of the liver
Figure 1. The activity of CD26/DPP4 in patient samples with lung adenocarcinoma. The measured activity is presented by ... Figure 1. The activity of CD26/DPP4.
NF-κB activation in pathogenesis and therapy of cancer.
Figure 3 Cytokine gene expression in PBMC stimulated with PPD or MBP in vitroCytokine messenger RNA transcripts were isolated from peripheral blood mononuclear.
A possible mechanism of renal cell death after ischemia/reperfusion
Components and outcomes of selected TNF-superfamily signalling pathways. Components and outcomes of selected TNF-superfamily signalling pathways. (Left)
Thomas A. Dewland et al. JACEP 2015;1:
Influence of the tumor microenvironment on FL
UAB Nanostring Laboratory
Diverse stimuli converge on PI3Kδ in B cells.
Magdalena Kluska University of Lodz
Presentation transcript:

DEPARTMENT OF CELL BIOLOGY Head: Dr. Jacek Bigda, Associate Professor Research Staff: Dr. Małgorzata Doszczak Dr. Patrycja Koszałka Dr. Zuzanna Dobrzańska Ph.D. Students: Marcin Okrój Arkadiusz Pierzchalski

MAIN TOPIC Mechanism of action of tumor necrosis factor (TNF) in vitro & in vivo TEACHING cell biology, histology, immunology

DEPARTMENT OF CELL BIOLOGY research interests:  mechanism of IL-1-induced cytotoxicity;  intracellular signaling of tumor necrosis factor;  mechanism of toxicity of the anti-angiogenic fumagillin derivative, TNP-470;  mechanism of anti-tumor action of poly-RGD peptides;  mechanism of accelerated growth of hamster melanoma following LPS application.

U 937 – human histiocytic lymphoma TNF-R55 F N TF N TF N T TNF-R75 F N T m F N T m F N T

Cycloheximide (CHX) U937 cell variants

U 937 M U 937 G U 937 ATCC

IL-1 cytotoxicity

control 4 h 2 h 0,5 h 1 h TNF [pg/ml] control CHX IL-1 IL-1/CHX IL-1 cytotoxicity

Isotype control Untreated IL-1/CHX

DEPARTMENT OF CELL BIOLOGY financial support:  Analysis of mechanism regulating secretion of TNF following application of interleukin 1 and cycloheximide; State Committee for Scientific Research, Poland ( );  Mechanism of synergistic anti-tumor action of tumor necrosis factor (TNF) and angiogenesis inhibitor TNP-470; State Committee for Scientific Research, Poland ( );  Analysis of TNF sensitivity of variants of the U937 cell line; Intramural grant, Medical University of Gdańsk ( );  Modulation of tumor growth by means of cytokines; Core fund, Intercollegiate Faculty of Biotechnology UG-MUG;

DEPARTMENT OF CELL BIOLOGY selected previous grants:  Significance of tumor necrosis factor and its receptors for growth and dissemination of Bomirski melanoma; State Committee for Scientific Research, Poland ( );  Immunomodulatory and anti-tumor activity of cloned and purified rat tumor necrosis factor; State Committee for Scientific Research, Poland ( );  Influence of receptors of tumor necrosis factor for apoptosis of cancer cells; State Committee for Scientific Research, Poland ( );  Mechanism of cytotoxic action of interleukin 1; State Committee for Scientific Research, Poland ( );  TNF gene polymorphism and humoral reactivity against p53 protein in patients suffering from non-small cell lung cancer; State Committee for Scientific Research, Poland( ).

Tri-City Central Animal Laboratory, Medical University of Gdańsk

Tri-CityCentral Animal Laboratory, Medical University of Gdańsk Tri-City Central Animal Laboratory, Medical University of Gdańsk